Scientists uncover new targets for treating Parkinson’s disease
LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have found that people with Parkinson’s disease have a clear
Neurodegenerative Diseases
The aim of this work funded by Aligning Science Across Parkinson’s (ASAP), in collaboration with Dr. Alessandro Sette, is to
Tuberculosis
The aim of this work, in collaboration with Dr. Bjoern Peters, is to identify and characterize T cell epitopes from
Once upon a BCG vaccine
LA JOLLA—A long, long time ago, the BCG vaccine was approved for use against tuberculosis (TB), and it’s still
New look at COVID-19 cases does not support link between BCG vaccination and lower mortality
Researchers tracking COVID-19 mortality early in the pandemic noticed that some countries had a significantly lower mortality rate than others.
LJI scientists receive $3.5 million to investigate role of immune cells in Parkinson’s disease
LA JOLLA—Scientists at the La Jolla Institute for Immunology (LJI) have received $3.5 million as part of a team award
LJI Scientists Link Immune Cells to Parkinson’s Disease Onset
LA JOLLA—A new study co-led by scientists at the La Jolla Institute for Immunology (LJI) adds increasing evidence that Parkinson’s